A Totally New Mechanism to Revitalize Hair Follicles
- First With the Stress-Blocking Peptide Astressin-B
- May Induce Follicles into Anagen Growth Phase
DS Labs is First With Astressin-B
Spectral.F7® is the first hair treatment to incorporate astressin-B, a peptide that is very long & complex, with a 30+ amino-acid sequence & includes a cyclo-lactam bridge. Astressin-B contains some unusual amino acids & unlike virtually all peptides in cosmetic use, it is particularly difficult to synthesize. This advancement in the art & science of hair solidifies DS Laboratories' reputation for developing cutting-edge technologies & bringing them to our customers first.
In newly published clinical research, the stress-hormone-blocking peptide astressin-B is credited with prevention of hair loss due to stress hormones.
Now Spectral.F7 is the first over-the-counter topical formula to incorporate astressin-B whose mechanism of action offers a completely new modality. In trails conducted by DS Laboratories, the foremost innovator of topical therapies, astressin-B shows unique benefits & high efficacy.
This formulation contains compounds that have been evaluated in clinical trials & subsequently tested & optimized in our own extensive trials. These materials are encapsulated in a range of Nanosome microspheres to enhance absorption & others are delivered in free form, for optimal delivery. Our evaluation of efficacy with volunteers has shown very promising results when used wither in early stages of thinning hair or in conjunction with other therapies in later stages.
Who Should Use Spectral.F7?
Men & women concerned about thinning hair & overall hair health can combine Spectral.F7 with existing therapies such as Spectral.DNC® for maximum benefit, or they can use the product as an effective stand-alone treatment.
Spectral.F7 features astressin-B, a peptide (protein fragment) with a very complex sequence newly discovered to block the receptors for corticotropin-releasing factor (CRF), invloved in the stress response. An in-vivo murine study investigated whether CFR blockage might influence hair growth when stress hormones are over-expressed & it showed a promising new mechanism of action on atrophic hair follicles.
Spectral.F7, from DS Laboratories, is the first topical solution to incorporate astressin-B.
DS Laboratroies is a wholly owned subsidiary of Divine Skin Comsumer Healthcare, a publicly traded company under the symbol DSKX.
Made in USA